(Q43013061)

12 November 2017

title

A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis (English)

1 reference

non-alcoholic steatohepatitis

12 November 2017

0 references

1 reference

1 reference

Jingmin Zhao

1

1 reference

12 November 2017

Guangde Zhou

2

1 reference

12 November 2017

Meirong Li

3

1 reference

12 November 2017

Wenshu Li

4

1 reference

12 November 2017

Jiyun Lü

5

1 reference

12 November 2017

Lu Xiong

6

1 reference

12 November 2017

Li Liang

7

1 reference

12 November 2017

Yulai Zhao

8

1 reference

12 November 2017

Dongping Xu

9

1 reference

12 November 2017

Jun Yu

10

1 reference

12 November 2017

publication date

21 June 2010

1 reference

Scandinavian Journal of Gastroenterology

12 November 2017

published in

1 reference

12 November 2017

volume

45

1 reference

12 November 2017

issue

11

1 reference

12 November 2017

page(s)

1360-1371

1 reference

Nonalcoholic fatty liver disease

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Metabolic and nutritional considerations in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Animal models of NASH: getting both pathology and metabolic context right

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Steatohepatitis induced by intragastric overfeeding in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

The homeostasis model in the San Antonio Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Animal models of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Signaling pathways in insulin action: molecular targets of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Ending propylthiouracil-induced liver failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Liver transplantation for acute liver failure from drug induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2010.497938

10.3109/00365521.2010.497938

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference